These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 21135695)
21. Sentinel lymph nodes containing very small (<0.1 mm) deposits of metastatic melanoma cannot be safely regarded as tumor-negative. Murali R; DeSilva C; McCarthy SW; Thompson JF; Scolyer RA Ann Surg Oncol; 2012 Apr; 19(4):1089-99. PubMed ID: 22271204 [TBL] [Abstract][Full Text] [Related]
22. Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial. Hoshimoto S; Shingai T; Morton DL; Kuo C; Faries MB; Chong K; Elashoff D; Wang HJ; Elashoff RM; Hoon DS J Clin Oncol; 2012 Nov; 30(31):3819-26. PubMed ID: 23008288 [TBL] [Abstract][Full Text] [Related]
23. Detection of micrometastasis in sentinel lymph nodes of patients with primary cutaneous melanoma. Blaheta HJ; Schittek B; Breuninger H; Garbe C Recent Results Cancer Res; 2001; 158():137-46. PubMed ID: 11092041 [TBL] [Abstract][Full Text] [Related]
24. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level. Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789 [TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node: detection of micrometastases of melanoma in a molecular study. Denninghoff VC; Kahn AG; Falco J; Curutchet HP; Elsner B Mol Diagn; 2004; 8(4):253-8. PubMed ID: 15887981 [TBL] [Abstract][Full Text] [Related]
26. Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Bieligk SC; Ghossein R; Bhattacharya S; Coit DG Ann Surg Oncol; 1999; 6(3):232-40. PubMed ID: 10340881 [TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of reverse transcriptase-polymerase chain reaction-negative sentinel nodes in malignant melanoma. Ribuffo D; Gradilone A; Vonella M; Chiummariello S; Cigna E; Haliassos N; Massa R; Silvestri I; Calvieri S; Frati L; Aglianò AM; Scuderi N Ann Surg Oncol; 2003 May; 10(4):396-402. PubMed ID: 12734088 [TBL] [Abstract][Full Text] [Related]
28. Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy. Takeuchi H; Taback B; Kuo C; Hoon DS Ann Surg Oncol; 2004 Mar; 11(3 Suppl):152S-5S. PubMed ID: 15023743 [TBL] [Abstract][Full Text] [Related]
29. Serial follow-up and the prognostic significance of reverse transcriptase-polymerase chain reaction--staged sentinel lymph nodes from melanoma patients. Kammula US; Ghossein R; Bhattacharya S; Coit DG J Clin Oncol; 2004 Oct; 22(19):3989-96. PubMed ID: 15459222 [TBL] [Abstract][Full Text] [Related]
31. Idiosyncrasies of scalp melanoma. Rigual NR; Cheney RT; Iwenofu OH; Li Q; Loree TR; Popat SR; Merzianu M Laryngoscope; 2007 Aug; 117(8):1354-8. PubMed ID: 17592396 [TBL] [Abstract][Full Text] [Related]
32. Detection of micrometastases in sentinel lymph nodes from melanoma patients: direct comparison of multimarker molecular and immunopathological methods. Rimoldi D; Lemoine R; Kurt AM; Salvi S; Berset M; Matter M; Roche B; Cerottini JP; Guggisberg D; Krischer J; Braun R; Willi JP; Antonescu C; Slosman D; Lejeune FJ; Liénard D; Melanoma Res; 2003 Oct; 13(5):511-20. PubMed ID: 14512793 [TBL] [Abstract][Full Text] [Related]
33. Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma. Hoshimoto S; Faries MB; Morton DL; Shingai T; Kuo C; Wang HJ; Elashoff R; Mozzillo N; Kelley MC; Thompson JF; Lee JE; Hoon DS Ann Surg; 2012 Feb; 255(2):357-62. PubMed ID: 22202581 [TBL] [Abstract][Full Text] [Related]
34. Quantitative real-time RT-PCR in sentinel lymph nodes from melanoma patients. Detection of melanocytic mRNA predicts disease-free survival. Riber-Hansen R; Abrahamsen HN; Sorensen BS; Hamilton-Dutoit SJ; Steiniche T APMIS; 2008 Mar; 116(3):199-205. PubMed ID: 18377585 [TBL] [Abstract][Full Text] [Related]
36. The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan. Ito T; Moroi Y; Oba J; Nakahara T; Takeuchi S; Uchi H; Takahara M; Masuda T; Furue M Melanoma Res; 2012 Feb; 22(1):38-44. PubMed ID: 22108607 [TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. Bostick PJ; Morton DL; Turner RR; Huynh KT; Wang HJ; Elashoff R; Essner R; Hoon DS J Clin Oncol; 1999 Oct; 17(10):3238-44. PubMed ID: 10506625 [TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of isolated HMB45 or Melan A positive cells in Melanoma sentinel lymph nodes. Satzger I; Völker B; Meier A; Schenck F; Kapp A; Gutzmer R Am J Surg Pathol; 2007 Aug; 31(8):1175-80. PubMed ID: 17667539 [TBL] [Abstract][Full Text] [Related]